Interspecies variation in toxicity of cholinesterase inhibitors

Toxicology of Organophosphate & Carbamate Compounds

Volumn , Issue , 2006, Pages 145-158

  Garcia, Stephanie J ^a   Aschner, Michael ^b   Syversen, Tore ^c  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650070343     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088523-7/50012-0     Document Type: Chapter

References (118)

1. Abou-Donia M. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 1981, 21:511-548.
2. Abou-Donia M. Toxicokinetics and metabolism of delayed neurotoxic organophosphorus esters. Neurotoxicology 1983, 4:113-129.
3. Aldridge J., Seidler F., Slotkin T. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: Critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect. 2004, 112:148-155.
4. Andersen R., Laake K., Fonnum F. Reactions between alkyl phosphates and acetylcholinesterase from different species. Comp. Biochem. Physiol. B 1972, 42:429-437.
5. Andersen R., Aaraas I., Gaare G., Fonnum F. Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methyl-sulphonyfluoride. Gen. Pharmacol. 1977, 8:331-334.
6. Anzueto A., Berdine G., Moore G., Gleiser C., Johnson D., White C., Johanson W.J. Pathophysiology of soman intoxication in primates. Toxicol. Appl. Pharmacol. 1986, 86:56-68.
7. Atterberry T., Burnett W., Chambers J. Age-related differences in parathion and chlorpyrifos toxicity in male rats: Target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism. Toxicol. Appl. Pharmacol. 1997, 147:411-418.
8. Barnes J., Denz F. Experimental demyelination with organophosphorus compounds. J. Pathol. Bacteriol. 1953, 65:597-605.
9. Becker R.E., Giacobini E. Mechanisms of Cholinesterase Inhibition in Senile Dementia of the Alzheimer Type-Clinical, Pharmacological, and Therapeutic Aspects. Drug Development Research 1988, 12(3-4):163-195.
10. Benschop H., De Jong L. Toxicokinetics of soman: Species variation and stereospecificity in elimination pathways. Neurosci. Biobehav. Rev. 1991, 15:73-77.
11. Blakley B., Yole M. Species differences in normal brain cholinesterase activities of animals and birds. Vet. Hum. Toxicol. 2002, 44:129-132.
12. Brimblecombe R., Green D., Stratton J., Thompson P. The protective actions of some anticholinergic drugs in sarin poisoning. Br. J. Pharmacol. 1970, 39:822-830.
13. Brodeur J., Dubois K. Comparison of acute toxicity of anticholinesterase insecticides to weanling and adult male rats. Proc. Soc. Exp. Biol. Med. 1963, 114:509-511.
14. Burbacher T., Rodier P., Weiss B. Methylmercury developmental neurotoxicity: A comparison of effects in humans and animals. Neurotoxicol. Teratol. 1990, 12:191-202.
15. Butler E., Eckerson H., La Du B. Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit. Drug Metab. Dispos. 1985, 13:640-645.
16. Buznikov G., Nikitina L., Bezuglov V., Lauder J., Padilla S., Slotkin T. An invertebrate model of the developmental neurotoxicity of insecticides: Effects of chlorpyrifos and dieldrin in sea urchin embryos and larvae. Environ. Health Perspect. 2001, 109:651-661.
17. Canadian Centre for Occupational Health and Safety Registry of Toxic Effects of Chemical Substances 2004, Canadian Centre for Occupational Health and Safety, Hamilton, Ontario, Canada.
18. Cavanagh J. The toxic effects of triortho-cresyl phosphate on the nervous system; An experimental study in hens. J. Neurochem. 1954, 17:163-172.
19. Cavanagh J. Organo-phosphorus neurotoxicity: A model "dying back" process comparable to certain human neurological disorders. Guys Hosp. Rep. 1963, 112:303-319.
20. Chambers J. The role of target site activation of phosphorothionates in acute toxicity. Organophosphates: Chemistry, Fate, and Effects 1992, 229-329. Academic Press, New York. J. Chambers, P. Levi (Eds.).
21. Chambers J., Chambers H. Time course of inhibition of acetylcholinesterase and aliesterases following parathion and paraoxon exposures in rats. Toxicol. Appl. Pharmacol. 1990, 103:420-429.
22. Chambers J., Ma T., Boone J., Chambers H. Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. Life Sci. 1994, 54:1357-1364.
23. Chhabra R., Pohl R., Fouts J. A comparative study of xenobiotic-metabolizing enzymes in liver and intestine of various animal species. Drug Metab. Dispos. 1974, 2:443-447.
24. Chippendale T., Zawolkow G., Russell R., Overstreet D. Tolerance to low acetylcholinesterase levels: modification of behavior without acute behavioral change. Psychopharmacologia 1972, 26:127-139.
25. Clement J.G. Importance of aliesterase as a detoxification mechanism for soman (pinacoloyl methylphosphonofluoridate) in mice. Biochemical Pharmacology 1984, 33(23):3807-3811.
26. Clothier B., Johnson M. Reactivation and aging of neurotoxic esterase inhibited by a variety of organophosphorus esters. Biochem. J. 1980, 185:739-747.
27. Cole R., Anderson G., Williams P. The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. Toxicol. Appl. Pharmacol. 2004, 194:248-256.
28. Cowan J., Sinton C., Varley A., Wians F., Haley R., Munford R. Gene therapy to prevent organophosphate intoxication. Toxicol. Appl. Pharmacol. 2001, 173:1-6.
29. Dam K., Garcia S.J., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 1999, 116:9-20.
30. Dam K., Seidler F.J., Slotkin T.A. Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Dev. Brain Res. 1999, 118:120-133.
31. Davies H., Richter R., Keifer M., Broomfield C., Sowalla J., Furlong C. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genet. 1996, 14:334-336.
32. deBethizy J., Hayes J. Metabolism: A determinant of toxicity. Principles and Methods of Toxicology 2001, 77-136. Taylor & Francis, Philadelphia. A. Hayes (Ed.).
33. de Jong L., Wolring G. Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species, including man, inhibited by soman. Biochem. Pharmacol. 1984, 33:1119-1125.
34. de Jong L., Wolring G. Aging and stereospecific reactivation of mouse erythrocyte and brain acetylcholinesterases inhibited by soman. Biochem. Pharmacol. 1985, 34:142-145.
35. Dorman D., Allen S., Byczkowski J., Claudio L., Fisher J.J., Fisher J., Harry G., Li A., Makris S., Padilla S., Sultatos L., Mileson B. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: Pharmacokinetic and pharmacodynamic considerations. Environ. Health Perspect. 2001, 109:101-111.
36. Dreyfus C.F. Neurotransmitters and neurotrophins collaborate to influence brain development. Perspect. Dev. Neurobiol. 1998, 5:389-399.
37. Eckerson H., Romson J., Wyte C., La Du B. The human serum paraoxonase polymorphism: Identification of phenotypes by their response to salts. Am. J. Hum. Genet. 1983, 35:214-227.
38. Ecobichon D. Toxic effects of pesticides. Casarett and Doull's Toxicology 2001, 763-810. McGraw-Hill, New York. C. Klaassen (Ed.).
39. Ecobichon D. Carbamate Insecticides. Handbook of Pesticide Toxicology 2001, 1087-1106. Academic Press, San Diego. R. Krieger (Ed.).
40. Ehrich M., Correll L., Strait J., McCain W., Wilcke J. Toxicity and toxicokinetics of carbaryl in chickens and rats: A comparative study. J. Toxicol. Environ. Health 1992, 36:411-423.
41. Ehrich M., Jortner B., Padilla S. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Fundam. Appl. Toxicol. 1995, 24:94-101.
42. El-Sebae A., Ahmed N., Soliman S. Effect of pre-exposure on acute toxicity of organophosphorus insecticides to white mice. J. Environ. Sci. Health B 1978, 13:11-24.
43. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 2003, 22:165-190.
44. Fahmy M., Fukuto T., Myers R., March R. The selective toxicity of new N-phosphorothioyl-carbamate esters. J. Agric. Food Chem. 1970, 18:793-796.
45. Fleisher J., Harris L., Prudhomme C., Bursel J. Effects of ethyl p-nitrophenyl thionobenzene phosphonate (Epn) on toxicity of isopropyl methyl phosphonofluoridate (Gb). J. Pharmacol. Exp. Ther. 1963, 139:390-396.
46. Forsberg A., Puu G. Kinetics for the inhibition of acetylcholinesterase from the electric eel by some organophosphates and carbamates. Eur. J. Biochem. 1984, 140:153-156.
47. Fromm M. Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 2004, 25:423-429.
48. Gaines T. The acute toxicity of pesticides to rats. Toxicol. Appl. Pharmacol. 1960, 2:88-89.
49. Gaines T. Acute toxicity of pesticides. Toxicol. Appl. Pharmacol. 1969, 14:515-534.
50. Garcia S.J., Seidler F.J., Crumpton T.L., Slotkin T.A. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res. 2001, 891:54-68.
51. Gow P., Ghabrial H., Smallwood R., Morgan D., Ching M. Neonatal hepatic drug elimination. Pharmacol. Toxicol. 2001, 88:3-15.
52. Grisaru D., Sternfeld M., Eldor A., Glick D., Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 1999, 264:672-686.
53. Grob D., Harvey J. Effects in man of the anticholinbesterase compound sarin (isopropyl methyl phospono-fluoridate). J. Clin. Invest. 1958, 37:350-368.
54. Grob D., Harvey A., Langworthy O. The administration of di-isopropyl fluorophosphate to man. 4. The effects on neuromuscular function in normal subjects and in myasthenia gravis. Johns Hopkins Hosp. Bull. 1947, 81:257-266.
55. Grunwald D., Eisen J. Headwaters of the zebrafish-Emergence of a new model vertebrate. Nat. Rev. Genet. 2002, 3:717-724.
56. Hitchcock M., Murphy S. Activation of parathion and guthion by mammalian, avian, and piscine liver homogenates and cell fractions. Toxicol. Appl. Pharmacol. 1971, 19:37-45.
57. Hodson P. A comparison of the acute toxicity of chemicals to fish, rats and mice. J. Appl. Toxicol. 1985, 5:220-226.
58. HuffR.A., Corcoran J.J., Anderson J.K., Abou-Donia M.B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharmacol. Exp. Ther. 1994, 269:329-335.
59. Hussain M., Oloffs P. Neurotoxic effects of leptophos (PhosvelR) in chickens and rats following chronic low-level feeding. J. Environ. Sci. health B 1979, 14:367-382.
60. Hutson D., Hathway D. Toxic effects of chlorfenvinphos in dogs and rats. Biochem. Pharmacol. 1967, 16:949-962.
61. Johnson J., Wallace K. Species-related differences in the inhibition of brain acetylcholinesterase by paraoxon and malaoxon. Toxicol. Appl. Pharmacol. 1987, 88:234-241.
62. Kaliste-Korhonen E., Tuovinen K., Hanninen O. Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro. Hum. Exp. Toxicol. 1996, 15:972-978.
63. Karanth S., Pope C. Carboxylesterase and A-esterase activities during maturation and aging: Relationship to the toxicity of chlorpyrifos and parathion in rats. Toxicol. Sci. 2000, 58:282-289.
64. Kato R. Possible role of P-450 in the oxidation of drugs in liver microsomes. J. Biochem. (Tokyo) 1966, 59:574-583.
65. Kemp J., Wallace K. Molecular determinants of the species-selective inhibition of brain acetylcholinesterase. Toxicol. Appl. Pharmacol. 1990, 104:246-258.
66. Klimmer O., PfaffW. Vergleichende untersuchungen uber die toxicitat organischer thiophosphorasaureester Arzneimittelforschung-Forschung. Drug Res. 1955, 5:626-630.
67. La Du B., Eckerson H. The polymorphic paraoxonase/arylesterase isozymes of human serum. Fed. Proc. 1984, 43:2338-2341.
68. Lanning C., Fine R., Sachs C., Rao U., Corcoran J., Abou-Donia M. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, p-glycoprotein. J. Toxicol. Environ. Health 1996, 47:395-407.
69. Lasker J., Graham D., Abou-Donia M. Differential metabolism of O-ethyl O-4-nitrophenyl phenylphosphonothioate by rat and chicken hepatic microsomes. Biochem. Pharmacol. 1982, 31:1961-1967.
70. Lauder J.M., Schambra U.B. Morphogenetic roles of acetylcholine. Environ. Health Perspect. 1999, 107(Suppl. 1):65-69.
71. Lauwerys R., Murphy S. Comparison of assay methods for studying O, O-diethyl, O-p-nitrophenyl phosphate (paraoxon) detoxication in vitro. Biochem. Pharmacol. 1969, 18:789-800.
72. Lotti M., Johnson M. Neurotoxicity of organophosphorus pesticides: Predictions can be based on in vitro studies with hen and human enzymes. Arch. Toxicol. 1978, 41:215-221.
73. Ma T., Chambers J. Kinetic parameters of desulfuration and dearylation of parathion and chlorpyrifos by rat liver microsomes. Food Chem. Toxicol. 1994, 32:763-767.
74. Maxwell D., Brecht K., O'Neill B. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol. Lett. 1987, 39:35-42.
75. Moser V., Chanda S., Mortensen S., Padilla S. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol. Sci. 1998, 46:211-222.
76. NatoffI. Organophosphorus pesticides: Pharmacology. Prog. Med. Chem. 1971, 8:1-37.
77. Natoff I., Reiff B. Effect of oximes on acute toxicity of anticholinesterase carbamates. Toxicol. Appl. Pharmacol. 1973, 25:569-575.
78. Nau H. Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Perspect. 1986, 70:113-129.
79. Neal R., Dubois K. Studies on the mechanism of detoxification of cholinergic phosphorothioates. J. Pharmacol. Exp. Ther. 1965, 148:185-192.
80. Nelson E., Raj P., BelfiK., Masters B. Oxidative drug metabolism in human liver microsomes. J. Pharmacol. Exp. Ther. 1971, 178:580-588.
81. Novak R., Padilla S. An in vitro comparison of rat and chicken brain neurotoxic esterase. Fundam. Appl. Toxicol. 1986, 6:464-471.
82. Olivier K., Liu J., Pope C. Inhibition of forskolin-stimulated cAMP formation in vitro by paraoxon and chlorpyrifos oxon in cortical slices from neonatal, juvenile, and adult rats. J. Biochem. Mol. Toxicol. 2001, 15:263-269.
83. Padilla S., Buzzard J., Moser V. Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos. Neurotoxicology 2000, 21:49-56.
84. Paulet G. Cholinesterase activity and function of the respiratory centers. J. Physiol. (Paris) 1956, 48:915-936.
85. Pelkonen O., Jouppila P., Karki N. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Arch. Int. Pharmacodyn. Ther. 1973, 202:288-297.
86. Pope C., Chakraborti T. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology 1992, 73:35-43.
87. Pope C., Chakraborti T., Chapman M., Farrar J., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology 1991, 68:51-61.
88. Pope C.N. Organophosphorus pesticides: Do they all have the same mechanism of toxicity?. J. Toxicol. Environm. Health 1999, 2:161-181.
89. Raffaele K., Rees C. Neurotoxicology dose/response assessment for several cholinesterase inhibitors: Use of uncertainty factors. Neurotoxicology 1990, 11:237-256.
90. Raines K.W., Seidler F.J., Slotkin T.A. Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Dev. Brain Res. 2001, 130:65-72.
91. Rosati A., Maniori S., Decorti G., Candussio L., Giraldi T., Bartoli F. Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny. Dev. Growth Differ. 2003, 45:377.
92. Schoene K., et al. The protective effect of oxime pretreatment upon the inhalative toxicity of sarin and soman in rats. Fundam. Appl. Toxicol. 1985, 5:S84-S88.
93. Sherman M., Herrick R., Ross E., Chang M. Further studies on acute and subacute toxicity of insecticides to chicks. Toxicol. Appl. Pharmacol. 1967, 11:49-67.
94. Skau K. Acetylcholinesterase molecular forms in serum and erythrocytes of laboratory animals. Comp. Biochem. Physiol. C 1985, 80:207-210.
95. Slotkin T. Developmental cholinotoxicants: Nicotine and chlorpyrifos. Environ. Health Perspect 1999, 107(Suppl. 1):71-80.
96. Slotkin T. Cholinergic systems in brain development and disruption by neurotoxicants: Nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 2004, 198:132-151.
97. Soliman S., Linder R., Farmer J., Curley A. Species susceptibility to delayed toxic neuropathy in relation to in vivo inhibition of neurotoxic esterase by neurotoxic organophosphorus esters. J. Toxicol. Environ. Health 1982, 9:189-197.
98. Song X., Seidler F.J., Saleh J.L., Zhang J., Padilla S., Slotkin T. Cellular mechanisms for developmental toxicity of chlorpyrifos: Targeting the adenylyl cyclase signaling cascade. Toxicol. Appl. Pharmacol. 1997, 145:158-174.
99. Stevens J., Breckenridge C. Crop protection chemicals. Principles and Methods of Toxicology 2001, 565-648. Taylor & Francis, Philadelphia. A. Hayes (Ed.).
100. Storm J., Rozman K., Doull J. Occupational exposure limits for 30 organophosphate pesticides based on inhibition of red blood cell acetylcholinesterase. Toxicology 2000, 150:1-29.
101. Sultatos L., Basker K., Shao M., Murphy S. The interaction of the phosphorothioate insecticides chlorpyrifos and parathion and their oxygen analogues with bovine serum albumin. Mol. Pharmacol. 1984, 26:99-104.
102. Thompson H. Avian serum esterases: Species and temporal variations and their possible consequences. Chem-Biol. Interact. 1993, 87:329-338.
103. Thompson H., Langton S., Hart A. Prediction of inter-species differences in the toxicity of organophosphorus pesticides to wildlife-A biochemical approach. Comp. Biochem. Physiol. C 1995, 111:1-12.
104. Veronesi B. Validation of a rodent model of organophosphorous-induced delayed neuropathy. Clinical and Exprimental Toxicology of Organophosphates and Carbamates 1992, 114-125. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
105. Veronesi B., Padilla S., Blackmon K., Pope C. Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN). Toxicol. Appl. Pharmacol. 1991, 107:311-324.
106. Vidair C. Age dependence of organophosphate and carbamate neurotoxicity in the postnatal rat: Extrapolation to the human. Toxicol. Appl. Pharmacol. 2004, 196:287-302.
107. Walker C., Mackness M. "A" esterases and their role in regulating the toxicity of organophosphates. Arch. Toxicol. 1987, 60:30-33.
108. Wallace K. Species-selective toxicity of organophosphorus insecticides: A pharmacodynamic phenomenon. Organophosphates: Chemistry, Fate, and Effects 1992, 79-105. Academic Press, New York. J. Chambers, P. Levi (Eds.).
109. Wallace K., Dargan J. Intrinsic metabolic clearance of parathion and paraoxon by livers from fish and rodents. Toxicol. Appl. Pharmacol. 1987, 90:235-242.
110. Wallace K., Herzberg U. Reactivation and aging of phosphorylated brain acetylcholinesterase from fish and rodents. Toxicol. Appl. Pharmacol. 1988, 92:307-314.
111. Wang C., Murphy S. Kinetic analysis of species difference in acetylcholinesterase sensitivity to organophosphate insecticides. Toxicol. Appl. Pharmacol. 1982, 66:409-419.
112. Ward T.R., Mundy W.R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res. Bull. 1996, 39:49-55.
113. Warrington J., Greenblatt D., von Moltke L. The effect of age on P-glycoprotein expression and function in the Fischer-344 rat. J. Pharmacol. Exp. Ther. 2004, 309:730-736.
114. Weiss L., Orzel R. Some comparative toxicologic and pharmacologic effects of dimethyl sulfoxide as a pesticide solvent. Toxicol. Appl. Pharmacol. 1967, 11:546-557.
115. Weiss E., Maness P., Lauder J. Why do neurotransmitters act like growth factors?. Perspect. Dev. Neurobiol. 1998, 5:323-335.
116. Yanai J., Vatury O., Slotkin T.A. Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Ann. NY Acad. Sci. 2002, 965:473-478.
117. Yanai J., Beer A., Huleihel R., Izrael M., Katz S., Levi Y., Rozenboim I., Yaniv S., Slotkin T. Convergent effects on cell signaling mechanisms mediate the actions of different neurobehavioral teratogens: Alterations in cholinergic regulation of protien kinase C in chick and avian models. Ann. N.Y. Acad. Sci. 2004, 1025:595-601.
118. Zhang H.S., Liu J., Pope C.N. Age-related effects of chlorpyrifos on muscarinic receptor-mediated signaling in rat cortex. Arch. Toxicol. 2002, 75.